Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
 
 

Nigeria Receives Record Praziquantel Donation

Nigeria's Minister of Health, Prof. Isaac Folorunso Adewole, expressed his country's thanks to Merck KGaA, Darmstadt, Germany and the World Health Organization for their joint efforts in the fight against the neglected tropical disease schistosomiasis. Our CEO Stefan Oschmann met the minister on the occasion of the 69th World Health Assembly today in Geneva.

First-Quarter Earning Rise Significantly

“We started off 2016 well and have grown profitably. The integration of Sigma-Aldrich is progressing quickly and we are also right on target with our debt reduction,” said Stefan Oschmann, CEO of our company.

Stefan Oschmann New CEO

Darmstadt, Germany, April 29, 2016 – New leadership at Merck KGaA, Darmstadt, Germany, with Stefan Oschmann taking the helm as the Chairman of the Executive Board and CEO. After nine years as CEO, Karl-Ludwig Kley handed over the executive leadership of the company to Oschmann at the AGM.

Our Company Counts on Africa for Growth

The Group’s Executive Board has visited 10 African countries this week to underscore its commitment and rising importance of the continent.

 

Media Services for the US and Canada

Latest Press Releases
Nigeria Receives Record Praziquantel Donation
Nigeria Receives Record Praziquantel Donation
Geneva, Switzerland, May 24, 2016 – Merck KGaA, Darmstadt, Germany, announced today that the largest single delivery of praziquantel tablets in the history our Praziquantel Donation Program recently arrived in Abuja, the capital of Nigeria. The West African country has received around 34 million tablets for mass distribution to school children.
 
First quarter results 2016
First quarter results 2016
“We started off 2016 well and have grown profitably. The integration of Sigma-Aldrich is progressing quickly and we are also right on target with our debt reduction,” said Stefan Oschmann, CEO of our company.
 
Merck KGaA, Darmstadt, Germany, and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting
Merck KGaA, Darmstadt, Germany, and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting
Darmstadt, Germany, and New York, US, May 18, 2016 – Merck KGaA, Darmstadt, Germany, and Pfizer today announced that avelumab* presentations across seven different tumor types, including two oral presentations, will be featured at the 52nd American Society of Clinical Oncology (ASCO) Annual Meeting being held June 3–7, 2016, in Chicago, IL.
 
 
top

OUR COMPANY IN THE MEDIA

OUR COMPANY IN THE MEDIA
Read how Merck KGaA, Darmstadt, Germany, and its affiliates are covered by media outlets around the world

DOWNLOAD LIBRARY

Download Library
Download images, Media Kits and other material from our media download library

CALENDAR OF EVENTS

Calendar of Events
Find and register for upcoming events

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK.  Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in healthcare, “MilliporeSigma” in life science and “EMD Performance Materials.”  The other company is Merck & Co., which uses the trademark MERCK only in the United States, Canada, Cuba and the Philippines.  Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.
           To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.
 

FOR MEDIA INQUIRIES, CONTACT

Media Team
POSTAL ADDRESS 
Merck KGaA, Darmstadt, Germany
Frankfurter Straße 250 
64293 Darmstadt 
Germany
Tel.: +49 6151 72-5000
Fax: +49 6151 72-3138
 

GENERAL INQUIRIES

Communications Center
Tel.: +49 6151 72-0
Fax: +49 6151 72-2000
 

FINANCIAL REPORT ON Q1 2016

Financial Report on Q1 2016
Merck KGaA, Darmstadt, Germany on Facebook
Twitter
 
  
Read more on M - The Explorer Magazine

LCD development

Displays have steadily undergone a series of innovations that have made colors more brilliant, lowered power consumption, and enabled 3D depictions. We are supplying the crucial substances.

Read more on M - The Explorer Magazine
Read more on M - The Explorer Magazine

An award-winning research process

In the development of innovative liquid crystals, we are building on the ideas of many. Important input is provided not only by the company’s own basic research, but also by customers.

Read more on M - The Explorer Magazine